Humacyte regains Nasdaq compliance after stock recovers above $1 minimum bid price

Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

• medium

  Nasdaq notified Humacyte on June 5, 2026 that it has regained compliance with the $1.00 minimum bid price requirement after the stock closed at or above $1.00 for 10 consecutive business days, resolving a prior deficiency.

  Item 3.01 view on EDGAR →
• medium

  The company had previously received a deficiency notice after its stock traded below $1.00 for 30 consecutive business days ending May 1, 2026, putting its Nasdaq Global Select Market listing at risk.

  8-K: Nasdaq Compliance verify on EDGAR →